{"DataElement":{"publicId":"6576595","version":"1","preferredName":"Gastric Cancer AJCC Edition 8 Pathologic Group Stage","preferredDefinition":"Pathologic stage group based on the combination of T, N, and M categories and relevant prognostic factors for gastric carcinoma, using AJCC Ed. 8 criteria.","longName":"GAST_AJC8_PTH_STG","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6576376","version":"1","preferredName":"Gastric Neoplasm Pathologic Stage Grouping","preferredDefinition":"Relating to the stomach._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Caused by or altered by or manifesting disease or pathology._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","longName":"3443882v1.0:2230144v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3443882","version":"1","preferredName":"Gastric Neoplasm","preferredDefinition":"Relating to the stomach.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C13307:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric","conceptCode":"C13307","definition":"Relating to the stomach.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE9BBA38-E583-4C0E-E040-BB89AD430CAC","latestVersionIndicator":"Yes","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"ONEDATA","dateModified":"2012-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2230144","version":"1","preferredName":"Pathologic Stage Grouping","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C25610:C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CCE-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"ONEDATA","dateModified":"2005-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7C202282-21A1-4053-E053-F662850A099C","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"TAYLORT","dateModified":"2019-08-30","changeDescription":"12/3/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6576497","version":"1","preferredName":"Gastric Carcinoma American Joint Committee on Cancer Edition 8 Pathologic Group Stage","preferredDefinition":"A term that refers to the pathologic staging of gastric cancer according to the American Joint Committee on Cancer, 8th edition._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"6576497v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IV","valueDescription":"Pathologic Stage IV Gastric Cancer AJCC v8","ValueMeaning":{"publicId":"6576499","version":"1","preferredName":"Pathologic Stage IV Gastric Cancer AJCC v8","longName":"6576499","preferredDefinition":"Stage IV includes: Any T, Any N. M1: Distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IV Gastric Cancer AJCC v8","conceptCode":"C133668","definition":"Stage IV includes: Any T, Any N. M1: Distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C25EBE0-F811-637D-E053-F662850AA308","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C25EBE0-F82A-637D-E053-F662850AA308","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"},{"value":"IIIC","valueDescription":"Pathologic Stage IIIC Gastric Cancer AJCC v8","ValueMeaning":{"publicId":"6576501","version":"1","preferredName":"Pathologic Stage IIIC Gastric Cancer AJCC v8","longName":"6576501","preferredDefinition":"Stage IIIC includes: (T3, N3b, M0); (T4a, N3b, M0); (T4b, N3a, M0); (T4b, N3b, M0). T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. T4a: Tumor invades the serosa (visceral peritoneum). T4b: Tumor invades adjacent structures/organs. N3a: Tumor with metastasis in seven to fifteen regional lymph nodes. N3b: Tumor with metastasis in sixteen or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IIIC Gastric Cancer AJCC v8","conceptCode":"C133667","definition":"Stage IIIC includes: (T3, N3b, M0); (T4a, N3b, M0); (T4b, N3a, M0); (T4b, N3b, M0). T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. T4a: Tumor invades the serosa (visceral peritoneum). T4b: Tumor invades adjacent structures/organs. N3a: Tumor with metastasis in seven to fifteen regional lymph nodes. N3b: Tumor with metastasis in sixteen or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C25EBE0-F837-637D-E053-F662850AA308","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C25EBE0-F850-637D-E053-F662850AA308","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"},{"value":"IIIB","valueDescription":"Pathologic Stage IIIB Gastric Cancer AJCC v8","ValueMeaning":{"publicId":"6576503","version":"1","preferredName":"Pathologic Stage IIIB Gastric Cancer AJCC v8","longName":"6576503","preferredDefinition":"Stage IIIB includes: (T1, N3b, M0); (T2, N3b, M0); (T3, N3a, M0); (T4a, N3a, M0); (T4b, N1, M0); (T4b, N2, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. T4a: Tumor invades the serosa (visceral peritoneum). T4b: Tumor invades adjacent structures/organs. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3a: Tumor with metastasis in seven to fifteen regional lymph nodes. N3b: Tumor with metastasis in sixteen or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IIIB Gastric Cancer AJCC v8","conceptCode":"C133666","definition":"Stage IIIB includes: (T1, N3b, M0); (T2, N3b, M0); (T3, N3a, M0); (T4a, N3a, M0); (T4b, N1, M0); (T4b, N2, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. T4a: Tumor invades the serosa (visceral peritoneum). T4b: Tumor invades adjacent structures/organs. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3a: Tumor with metastasis in seven to fifteen regional lymph nodes. N3b: Tumor with metastasis in sixteen or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C25EBE0-F85D-637D-E053-F662850AA308","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C25EBE0-F876-637D-E053-F662850AA308","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"Pathologic Stage IIIA Gastric Cancer AJCC v8","ValueMeaning":{"publicId":"6576505","version":"1","preferredName":"Pathologic Stage IIIA Gastric Cancer AJCC v8","longName":"6576505","preferredDefinition":"Stage IIIA includes: (T2, N3a, M0); (T3, N2, M0); (T4a, N1, M0); (T4a, N2, M0); (T4b, N0, M0). T2: Tumor invades the muscularis propria. T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. T4a: Tumor invades the serosa (visceral peritoneum). T4b: Tumor invades adjacent structures/organs.  N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3a: Tumor with metastasis in seven to fifteen regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IIIA Gastric Cancer AJCC v8","conceptCode":"C133665","definition":"Stage IIIA includes: (T2, N3a, M0); (T3, N2, M0); (T4a, N1, M0); (T4a, N2, M0); (T4b, N0, M0). T2: Tumor invades the muscularis propria. T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. T4a: Tumor invades the serosa (visceral peritoneum). T4b: Tumor invades adjacent structures/organs.  N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3a: Tumor with metastasis in seven to fifteen regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C25EBE0-F883-637D-E053-F662850AA308","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C25EBE0-F89C-637D-E053-F662850AA308","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Pathologic Stage IIB Gastric Cancer AJCC v8","ValueMeaning":{"publicId":"6576507","version":"1","preferredName":"Pathologic Stage IIB Gastric Cancer AJCC v8","longName":"6576507","preferredDefinition":"Stage IIB includes: (T1, N3a, M0); (T2, N2, M0); (T3, N1, M0); (T4a, N0, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. T4a: Tumor invades the serosa (visceral peritoneum). N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3a: Tumor with metastasis in seven to fifteen regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IIB Gastric Cancer AJCC v8","conceptCode":"C133662","definition":"Stage IIB includes: (T1, N3a, M0); (T2, N2, M0); (T3, N1, M0); (T4a, N0, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. T4a: Tumor invades the serosa (visceral peritoneum). N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3a: Tumor with metastasis in seven to fifteen regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C25EBE0-F8A9-637D-E053-F662850AA308","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C25EBE0-F8C2-637D-E053-F662850AA308","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Pathologic Stage IIA Gastric Cancer AJCC v8","ValueMeaning":{"publicId":"6576509","version":"1","preferredName":"Pathologic Stage IIA Gastric Cancer AJCC v8","longName":"6576509","preferredDefinition":"Stage IIA includes: (T1, N2, M0); (T2, N1, M0); (T3, N0, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IIA Gastric Cancer AJCC v8","conceptCode":"C133660","definition":"Stage IIA includes: (T1, N2, M0); (T2, N1, M0); (T3, N0, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C25EBE0-F8CF-637D-E053-F662850AA308","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C25EBE0-F8E8-637D-E053-F662850AA308","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"},{"value":"IB","valueDescription":"Pathologic Stage IB Gastric Cancer AJCC v8","ValueMeaning":{"publicId":"6576511","version":"1","preferredName":"Pathologic Stage IB Gastric Cancer AJCC v8","longName":"6576511","preferredDefinition":"Stage IB includes: (T1, N1, M0); (T2, N0, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IB Gastric Cancer AJCC v8","conceptCode":"C133657","definition":"Stage IB includes: (T1, N1, M0); (T2, N0, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C25EBE0-F8F5-637D-E053-F662850AA308","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C25EBE0-F90E-637D-E053-F662850AA308","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"},{"value":"IA","valueDescription":"Pathologic Stage IA Gastric Cancer AJCC v8","ValueMeaning":{"publicId":"6576513","version":"1","preferredName":"Pathologic Stage IA Gastric Cancer AJCC v8","longName":"6576513","preferredDefinition":"Stage IA includes: (T1, N0, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IA Gastric Cancer AJCC v8","conceptCode":"C133656","definition":"Stage IA includes: (T1, N0, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C25EBE0-F91B-637D-E053-F662850AA308","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C25EBE0-F934-637D-E053-F662850AA308","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"},{"value":"0","valueDescription":"Pathologic Stage 0 Gastric Cancer AJCC v8","ValueMeaning":{"publicId":"6576515","version":"1","preferredName":"Pathologic Stage 0 Gastric Cancer AJCC v8","longName":"6576515","preferredDefinition":"Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ: intraepithelial tumor without invasion of the lamina propria, high grade dysplasia. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage 0 Gastric Cancer AJCC v8","conceptCode":"C133654","definition":"Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ: intraepithelial tumor without invasion of the lamina propria, high grade dysplasia. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C25EBE0-F941-637D-E053-F662850AA308","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C25EBE0-F95A-637D-E053-F662850AA308","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6576496","version":"1","preferredName":"Gastric Cancer by AJCC v8 Pathologic Stage Stage Grouping Stage","preferredDefinition":"A term that refers to the pathologic staging of gastric cancer according to the American Joint Committee on Cancer, 8th edition.:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C133640:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer by AJCC v8 Pathologic Stage","conceptCode":"C133640","definition":"A term that refers to the pathologic staging of gastric cancer according to the American Joint Committee on Cancer, 8th edition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C25EBE0-F7E4-637D-E053-F662850AA308","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7C25EBE0-F7F5-637D-E053-F662850AA308","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"TAYLORT","dateModified":"2019-08-30","changeDescription":"8/30/19 TMT released per MC.; 12/3/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"10000182","version":"1","longName":"Stomach","context":"NCI Standards"}]},{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"6570064","version":"1","longName":"Stomach","context":"OCCPR"},{"publicId":"6779566","version":"1","longName":"STAD Baseline","context":"OCCPR"}]}],"AlternateNames":[{"name":"OCCPR","type":"USED_BY","context":"OCCPR"}],"ReferenceDocuments":[{"name":"Pathologic disease stage","type":"Preferred Question Text","description":"Pathologic disease stage","url":null,"context":"NCI Standards"},{"name":"CPTAC-BSLN-1","type":"Alternate Question Text","description":"Tumor Stage (Pathologic)","url":null,"context":"OCCPR"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7C340F1C-B6F4-033C-E053-F662850AEBF6","latestVersionIndicator":"Yes","beginDate":"2018-12-04","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-04","modifiedBy":"KNABLEJ","dateModified":"2019-12-02","changeDescription":"8/30/19 TMT released per MC.; 12/4/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}